Hilarius 2008.
Methods | Sequential cohort design with repeated measures ‐ with intervention group (IG) and control group (CG) | |
Participants | Cancer patients who were to begin adjuvant or palliative chemotherapy treatment Country: the Netherlands Age: Participants: IG: mean 57 years; CG: mean 55 years, P = 0.17; Nurses: mean 36 years (26 to 48) Sex: Participants: IG: 61% female; CG: 67% female, P = 0.54; Nurses: 100% female Inclusion criteria
Exclusion criteria: Patients
N recruited: Participants: N = 298; IG: n = 148; CG: n = 150; Nurses: N = 10 N in analysis: Participants: N = 219; IG: n = 111; CG: n = 108; Nurses: N = 10 |
|
Interventions |
Content of screen:HRQoL: tool = EORTC QLQ‐C30: validated HRQoL measure with 5 functional scales, 9 symptom scales, and 2 General Health and QoL items, no total score can be computed. If applicable, a specific module for breast cancer (QLQ‐BR23), colorectal cancer (QLQ‐CR38), or lung cancer (QLQ‐LC13) was added. Screenings interventionist: No interventionist for screening act, self‐completion of screening tool. Intervention procedure:Solitary SI: Participants completed the EORTC questionnaire on touch screen computer in outpatient clinic. A graphic results summary was generated and given to participant and nurse before consultation (outpatient visit 2, 3, 4, 5 = study visit 1, 2, 3, 4). No specific guidelines were provided on how the HRQoL summary data could/should be used during consultations Conditions for implementation
Comparative condition: CG: usual care Length of follow‐up: 4 consecutive outpatient visits |
|
Outcomes |
Primary outcomes
Secondary outcomes: / Outcome time points: Second outpatient visit (first study visit = baseline); fifth outpatient visit (fourth study visit) |
|
Notes | For bias judgement on NRCTs, see Table 3; Table 4; Table 9 |